Qbiotics, page-21

Seems Stelfonta is making great strides. Virbac really pushing theatment. Latest today

Virbac offers complimentary oncology CPD for vet nurses alongside launch of Stelfonta

Virbac is hosting two complimentary ‘Seeing is Believing’ CPD webinars alongside the launch of Stelfonta, its new injectable treatment for mast cell tumours in dogs. On Tuesday 8th September Dr Owen Davies, an RCVS and American Specialist in Veterinary Oncology, will present ‘Mast Cell Tumours: An Update’, in which he will review mast cell tumours and diagnostic approaches before appraising the current treatment options.On Wednesday 9th September Dr Pam Jones, a double board certified Specialist in Veterinary Medical Oncology and Radiation Oncology from the US, will present ‘Stelfonta: Seeing is Believing’.Dr Jones will introduce delegates to the unique mode of action of tigilanol tiglate, review the efficacy data behind the new product and demonstrate how this treatment can be used to provide a high tumour elimination rate, wound healing and a speedy return to a good quality of life for the pet.Dr Neil Mottram, Technical Product Manager at Virbac said: “The effects of Stelfonta really do need to be seen to be believed, so we’re excited to offer vets the opportunity to learn more about this ground-breaking advancement in veterinary oncology. We are lucky to have secured some fantastic speakers for the webinars so delegates can be assured of some top quality CPD.”Both events will be hosted by The Webinar Vet and begin at 7:30pm. Registration for the event is now open and can be found at www.thewebinarvet.com/stelfontaFor more information, speak to your Virbac Territory Manager or visit vet-uk.virbac.com/stelfonta